<SEC-DOCUMENT>0000950170-25-029047.txt : 20250227
<SEC-HEADER>0000950170-25-029047.hdr.sgml : 20250227
<ACCEPTANCE-DATETIME>20250227161130
ACCESSION NUMBER:		0000950170-25-029047
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		13
CONFORMED PERIOD OF REPORT:	20250227
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250227
DATE AS OF CHANGE:		20250227

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Ventyx Biosciences, Inc.
		CENTRAL INDEX KEY:			0001851194
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				832996852
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40928
		FILM NUMBER:		25678852

	BUSINESS ADDRESS:	
		STREET 1:		12790 EL CAMINO REAL, SUITE 200
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92130
		BUSINESS PHONE:		(858) 945-2393

	MAIL ADDRESS:	
		STREET 1:		12790 EL CAMINO REAL, SUITE 200
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92130
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>vtyx-20250227.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- DFIN New ActiveDisclosure (SM) Inline XBRL Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2025-02-27T14:20:41.4301+00:00 -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:nonNumeric="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:vtyx="http://ventyxbio.com/20250227" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2022-02-16">
 <head>
  <title>8-K</title>
  <meta http-equiv="Content-Type" content="text/html"/>
 </head>
 <body style="padding:8px;margin:auto!important;">
  <div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric id="F_79cd09e6-8d88-4f57-8559-2f42b7641899" name="dei:EntityCentralIndexKey" contextRef="C_9de76f1a-2577-4f63-89af-d1ee4f103041">0001851194</ix:nonNumeric><ix:nonNumeric id="F_20c918c3-cecf-4582-9a76-0ab6a349c447" name="dei:AmendmentFlag" contextRef="C_9de76f1a-2577-4f63-89af-d1ee4f103041">false</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="vtyx-20250227.xsd"/></ix:references><ix:resources><xbrli:context id="C_9de76f1a-2577-4f63-89af-d1ee4f103041"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851194</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-02-27</xbrli:startDate><xbrli:endDate>2025-02-27</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>
  <div style="z-index:-3;min-height:0.5in;position:relative;"></div>
  <p style="border-top:2.25pt double #000000;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:5.75pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">UNITED STATES<br/>SECURITIES AND EXCHANGE COMMISSION<br/></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">WASHINGTON, D.C. 20549</span></p>
  <p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">FORM </span><span style="font-size:18pt;font-family:Times New Roman;"><ix:nonNumeric id="F_4bccf428-64e8-4e8f-bfa4-a9301cb41d12" contextRef="C_9de76f1a-2577-4f63-89af-d1ee4f103041" name="dei:DocumentType"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">8-K</span></ix:nonNumeric></span></p>
  <p style="margin-left:40%;font-size:10pt;margin-top:1pt;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CURRENT REPORT</span></p>
  <p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:6pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</span></p>
  <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:100%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.02986111111111111in;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Date of Report (Date of earliest event reported): </span><span><ix:nonNumeric id="F_753981bd-eced-472f-896f-59965f4f7871" contextRef="C_9de76f1a-2577-4f63-89af-d1ee4f103041" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">February 27, 2025</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="margin-left:40%;font-size:10pt;margin-top:5pt;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:5pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:24pt;font-family:Times New Roman;"><ix:nonNumeric id="F_1a457481-b1d8-4484-b553-4d8ed5fe20dd" contextRef="C_9de76f1a-2577-4f63-89af-d1ee4f103041" name="dei:EntityRegistrantName"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:24pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">VENTYX BIOSCIENCES, INC.</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(Exact name of Registrant as Specified in Its Charter)</span></p>
  <p style="margin-left:40%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:20%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:20%;box-sizing:content-box;"/>
    <td style="width:18%;box-sizing:content-box;"/>
    <td style="width:41%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td colspan="3" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_1c04eaf4-b91b-4d7c-b7e4-6ed1aa8ef06b" contextRef="C_9de76f1a-2577-4f63-89af-d1ee4f103041" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Delaware</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_0c8dce43-c0c5-45d1-923c-dd570ef54967" contextRef="C_9de76f1a-2577-4f63-89af-d1ee4f103041" name="dei:EntityFileNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">001-40928</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_0595deec-0ed2-44b0-b29a-896ebd629b08" contextRef="C_9de76f1a-2577-4f63-89af-d1ee4f103041" name="dei:EntityTaxIdentificationNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">83-2996852</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:7pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td colspan="3" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(State or Other Jurisdiction<br/>of Incorporation)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(Commission File Number)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(IRS Employer<br/>Identification No.)</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td colspan="3" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_d4bd8f42-e98f-41ce-9996-631725f2103d" contextRef="C_9de76f1a-2577-4f63-89af-d1ee4f103041" name="dei:EntityAddressAddressLine1"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">12790 El Camino Real</span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_497924d1-7d04-42ad-9b1e-d17074f3f63c" contextRef="C_9de76f1a-2577-4f63-89af-d1ee4f103041" name="dei:EntityAddressAddressLine2"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Suite 200</span></ix:nonNumeric></span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td colspan="3" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_4f3469d2-3473-4f78-933d-73a46f8a7921" contextRef="C_9de76f1a-2577-4f63-89af-d1ee4f103041" name="dei:EntityAddressCityOrTown"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">San Diego</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">, </span><span><ix:nonNumeric id="F_a5d6e95b-095e-4fa5-80b1-ab4d3d40973d" contextRef="C_9de76f1a-2577-4f63-89af-d1ee4f103041" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">California</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_418f5b70-8632-40b2-a9bd-33e593f7aa00" contextRef="C_9de76f1a-2577-4f63-89af-d1ee4f103041" name="dei:EntityAddressPostalZipCode"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">92130</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:7pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td colspan="3" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(Address of Principal Executive Offices)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(Zip Code)</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:100%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0.125in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.02986111111111111in;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Registrant&#8217;s Telephone Number, Including Area Code:</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span><span><ix:nonNumeric id="F_e0aa5148-a007-4a27-b25c-91aa8453b66a" contextRef="C_9de76f1a-2577-4f63-89af-d1ee4f103041" name="dei:CityAreaCode"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">760</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span><span><ix:nonNumeric id="F_ac3cb786-7b6d-4f2f-b370-0a7831a7526d" contextRef="C_9de76f1a-2577-4f63-89af-d1ee4f103041" name="dei:LocalPhoneNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">593-4832</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:100%;box-sizing:content-box;"/>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0.125in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(Former Name or Former Address, if Changed Since Last Report)</span></p>
  <p style="margin-left:40%;font-size:10pt;margin-top:9.35pt;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:9.35pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:9pt;margin-bottom:0;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_dfa7e7fb-7ed9-4572-8527-12f0bce4db69" contextRef="C_9de76f1a-2577-4f63-89af-d1ee4f103041" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div>
  <div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:6pt;margin-bottom:0;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_46f00ca3-c34d-484c-98e6-cc4fb8229c85" contextRef="C_9de76f1a-2577-4f63-89af-d1ee4f103041" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div>
  <div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:6pt;margin-bottom:0;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_1701d654-3ecb-4cf1-887c-62138e8b00c9" contextRef="C_9de76f1a-2577-4f63-89af-d1ee4f103041" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div>
  <div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:6pt;margin-bottom:0;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_4d56c588-3a27-4247-945f-9daf712986f0" contextRef="C_9de76f1a-2577-4f63-89af-d1ee4f103041" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div>
  <p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:9pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Securities registered pursuant to Section 12(b) of the Act:</span></p>
  <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:38%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:15%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:45%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;border-bottom:0.25pt solid;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><br/>Title of each class</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;border-bottom:0.25pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;border-bottom:0.25pt solid;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Trading<br/>Symbol(s)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;border-bottom:0.25pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;border-bottom:0.25pt solid;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><br/>Name of each exchange on which registered</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_73b506a4-1d59-4fe6-86b2-fb171ee12c92" contextRef="C_9de76f1a-2577-4f63-89af-d1ee4f103041" name="dei:Security12bTitle"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Common Stock, $0.0001 par value per share</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_9b870e1d-d264-4ffd-9d35-169363e0ea21" contextRef="C_9de76f1a-2577-4f63-89af-d1ee4f103041" name="dei:TradingSymbol"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">VTYX</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_da4b0a7f-7e50-4ea0-8a9a-cdb5f324aad3" contextRef="C_9de76f1a-2577-4f63-89af-d1ee4f103041" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">The Nasdaq Global Select Market</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;&#8239;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;&#8239;240.12b-2 of this chapter).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Emerging growth company </span><span style="font-size:10pt;"><ix:nonNumeric id="F_cc910988-d5ae-4fd5-8589-c2c6d44c78fe" contextRef="C_9de76f1a-2577-4f63-89af-d1ee4f103041" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:2.25pt double #000000;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="z-index:-3;min-height:0.5in;position:relative;"></div>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 2.02 Results of Operations and Financial Condition.</span></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On February 27, 2025, Ventyx Biosciences, Inc. (the &#8220;Company&#8221;) issued a press release announcing its financial results for the fourth quarter and year ended December 31, 2024. A copy of the press release is furnished herewith as Exhibit 99.1 to this Current Report on Form 8-K.</span></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The information in Item 2.02 of this Current Report on Form 8-K and Exhibit 99.1 attached hereto is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that section. The information in this Current Report on Form 8-K shall not be incorporated by reference in any filing under the Securities Act of 1933, as amended, or in any filing under the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 9.01 Financial Statements and Exhibits.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(d)  Exhibits.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:13.62%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:85.38%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;border-bottom:1pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Exhibit No.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;border-bottom:1pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;border-bottom:1pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Description</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">99.1</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="vtyx-ex99_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Press Release, dated February 27, 2025</span></a></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">104</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="z-index:-3;min-height:0.5in;position:relative;"></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:9.35pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SIGNATURES</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:9.35pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></p>
  <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:6%;box-sizing:content-box;"/>
    <td style="width:44%;box-sizing:content-box;"/>
    <td style="width:4%;box-sizing:content-box;"/>
    <td style="width:46%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">VENTYX BIOSCIENCES, INC.</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Date:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">February 27, 2025</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;border-bottom:0.25pt solid;text-align:left;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Raju Mohan</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Raju Mohan, Ph.D.<br/>Chief Executive Officer and Director</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
 </body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>vtyx-ex99_1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html>
 <head>
  <title>EX-99.1</title>
 </head>
 <body style="padding:8px;margin:auto!important;">
  <div style="z-index:-3;min-height:0.5in;position:relative;"></div>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 99.1</font></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img90346216_0.jpg" alt="img90346216_0.jpg" style="width:182px;height:57px;"></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Ventyx Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Corporate Progress</font></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Topline data readouts from multiple Phase 2 studies expected throughout 2025</font></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">VTX2735 in patients with recurrent pericarditis in H2</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">VTX3232 in participants with obesity and cardiometabolic risk factors in H2</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">VTX3232 biomarker study in patients with early Parkinson's disease in Q2</font></div></div>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Cash, cash equivalents and marketable securities balance of $252.9M as of December 31, 2024 expected to fund operations into at least H2 2026</font></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SAN DIEGO, CA, February 27, 2025 (GLOBE NEWSWIRE) -- Ventyx Biosciences, Inc. (Nasdaq: VTYX) (&#x201c;Ventyx&#x201d;, &#x201c;Company&#x201d;), a clinical-stage biopharmaceutical company focused on developing innovative oral therapies for patients with autoimmune, inflammatory, and neurodegenerative diseases, today reported fourth quarter and full year 2024 financial results and highlighted recent pipeline and business progress.</font></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;Heading into 2025, Ventyx has established itself as the leader in the field of NLRP3 inhibition having progressed two novel inhibitors, VTX3232 and VTX2735, into Phase 2 trials in neurodegenerative, cardiovascular, and metabolic indications. These disease states are thought to be driven by pathologic activation of the NLRP3 inflammasome,&#x201d; said Raju Mohan, PhD, President and Chief Executive Officer. &#x201c;We are on track to complete  the Phase 2 biomarker trial of VTX3232 in Parkinson&#x2019;s disease in Q2 2025 and have initiated planning for the next phase of development. In the second half of 2025, we expect to share results from the Phase 2 trial of VTX3232 in participants with obesity and cardiometabolic risk factors and the Phase 2 trial of VX2735 in patients with recurrent pericarditis. 2025 promises to be an exciting year for Ventyx and we look forward to sharing data and development plans as they become available.&#x201d;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pipeline Updates and Anticipated Milestones</font></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">NLRP3 Inhibitor Portfolio</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">: Ventyx is advancing a portfolio of potential best-in-class oral NLRP3 inhibitors for systemic inflammatory conditions and neurodegenerative diseases, including VTX2735, a peripherally restricted NLRP3 inhibitor, and VTX3232, a CNS-penetrant NLRP3 inhibitor.</font></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">VTX2735 in Recurrent Pericarditis</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">: We are evaluating VTX2735 in an open-label Phase 2 trial in patients with recurrent pericarditis. The trial will enroll approximately 30 patients for a 6-week primary treatment period, followed by a <br>7-week extension period. Key endpoints include safety, change in the NRS (numerical rating scale) pain score, and change in high sensitivity C-reactive protein (hsCRP). Topline results are expected in the second half of 2025.</font></div></div>
  <p style="margin-left:9.067%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">By treating and preventing disease recurrence, VTX2735 has the potential to offer a safe, effective, and convenient oral therapy for patients suffering from recurrent pericarditis.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">VTX3232 in Cardiometabolic Diseases</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">: We are evaluating VTX3232 in a Phase 2 trial in participants with obesity and cardiometabolic risk factors. The trial is expected to enroll approximately 160 subjects randomized to one of four groups for a 12-week primary treatment period: monotherapy placebo, monotherapy VTX3232, combination semaglutide + placebo, or combination semaglutide + VTX3232. Key endpoints include safety and change in hsCRP. The trial will assess a panel of exploratory endpoints, including biomarkers of inflammation and cardiometabolic disease, as well as imaging to assess body composition and liver fat. Topline results are expected in the second half of 2025. </font></div></div>
  <p style="margin-left:9.067%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Data from the Phase 2 trial are expected to inform future development of the Company's NLRP3 inhibitors in cardiometabolic diseases.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="z-index:-3;min-height:0.5in;position:relative;"></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">VTX3232 in Parkinson&#x2019;s Disease</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">: The ongoing Phase 2 open-label biomarker and imaging trial of VTX3232 in patients with early Parkinson&#x2019;s disease is on track to complete in the second quarter of 2025. Key endpoints include safety, pharmacokinetics, and inflammatory and disease-related biomarkers in cerebrospinal fluid and plasma, downstream of NLRP3 activation. The trial also includes exploratory TSPO (Translocator Protein) PET imaging as a marker of microglial activation.  </font></div></div>
  <p style="margin-left:9.067%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Data from the Phase 2 study are expected to inform future development of VTX3232 in Parkinson's disease. Beyond Parkinson&#x2019;s disease, NLRP3 inhibition in the CNS may have therapeutic utility in a range of other neurodegenerative diseases, including Alzheimer&#x2019;s disease, multiple sclerosis, and amyotrophic lateral sclerosis.</font></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Inflammatory Bowel Disease (IBD) Portfolio:</font></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Tamuzimod (S1P1R Modulator, ulcerative colitis)</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">: Publication of the tamuzimod  Phase 2 induction data in </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Lancet</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (January 2025, </font><font><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">doi:10.1016/S2468-1253(24)00386-8</font></font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">) highlighted robust clinical and endoscopic remission rates in patients treated with tamuzimod compared to placebo. Combination treatment is emerging as a compelling concept in IBD to break through the modest clinical remission rates seen with monotherapies today. Tamuzimod's efficacy and safety profile could position it as the backbone of future combination regimens with another oral or biologic agent. The Company continues to explore partnership opportunities for tamuzimod in ulcerative colitis.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">VTX958 (TYK2 Inhibitor, Crohn&#x2019;s disease)</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">: Presentation of Phase 2 data for VTX958 in Crohn&#x2019;s disease at the 20</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">th</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Congress of the European Crohn&#x2019;s and Colitis Organisation (ECCO, February 2025, </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Journal of Crohn's and Colitis</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, </font><font><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">doi.org/10.1093/ecco-jcc/jjae190.1175</font></font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">) demonstrated a robust, dose-dependent endoscopic response at Week 12 for VTX958 compared to placebo, including a greater magnitude of reduction in two key biomarkers of inflammation, CRP and fecal calprotectin. </font></div></div>
  <p style="margin-left:9.067%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The totality of the Phase 2 data suggest that VTX958 may have disease-modifying benefits in Crohn&#x2019;s disease. We are exploring a path for continued development of VTX958 in Crohn's disease, including potential partnership opportunities.</font></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Fourth Quarter and 2024 Financial Results</font></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cash Position</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">: Cash, cash equivalents and marketable securities were $252.9 million as of December 31, 2024. We believe our current cash, cash equivalents and marketable securities are sufficient to fund our planned operations into at least the second half of 2026.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Research</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">and Development (R&amp;D) expenses</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">: R&amp;D expenses were $24.8 million for the fourth quarter of 2024, compared to $42.0 million for the fourth quarter of 2023. R&amp;D expenses were $117.0 million for the year ended December 31, 2024, compared to $175.8 million for the year ended December 31, 2023.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">General and Administrative (G&amp;A) expenses</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">: G&amp;A expenses were $7.6 million for the fourth quarter of 2024, compared to $8.3 million for the fourth quarter of 2023. G&amp;A expenses were $31.4 million for the year ended December 31, 2024, compared to $32.2 million for the year ended December 31, 2023.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Net loss</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">: Net loss was $29.4 million for the fourth quarter of 2024, compared to $46.8 million for the fourth quarter of 2023. Net loss was $135.1 million for the year ended December 31, 2024, compared to $193.0 million for the year ended December 31, 2023.</font></div></div>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">About Ventyx Biosciences</font></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Ventyx Biosciences is a clinical-stage biopharmaceutical company developing innovative oral therapies for patients with autoimmune, inflammatory, and neurodegenerative diseases. Our expertise in medicinal chemistry, structural biology, and immunology enables the discovery of differentiated oral small molecule therapeutics for conditions with high unmet medical need, and our extensive experience in clinical development allows the rapid progression of these drug candidates through clinical trials. Our lead portfolio of NLRP3 inhibitors includes VTX2735, a peripherally restricted NLRP3 inhibitor in Phase 2 development for recurrent pericarditis, and VTX3232, a CNS-penetrant NLRP3 inhibitor in Phase 2 development for neurodegenerative and cardiometabolic diseases. Our inflammatory bowel disease portfolio includes tamuzimod (VTX002), an S1P1R modulator, and VTX958, a TYK2 inhibitor, both of which have completed Phase 2 clinical trials. For more information on Ventyx, please visit our website at </font><font><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">https://ventyxbio.com</font></font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="z-index:-3;min-height:0.5in;position:relative;"></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Forward-Looking Statements</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Ventyx cautions you that statements contained in this press release regarding matters that are not historical facts are forward-looking statements. These statements are based on Ventyx&#x2019;s current beliefs and expectations. Such forward-looking statements include, but are not limited to, statements regarding: the potential of each of Ventyx&#x2019;s product candidates, including the potential of VTX2735 and VTX3232, to emerge as best-in-class NLRP3 inhibitors and produce safe, effective or disease modifying results for the treatment of systemic inflammatory conditions or neurodegenerative diseases, the anticipated timing of enrollment of subjects, and the estimated total subjects enrolled, in each of the Phase 2 trials; the anticipated timing for the topline results of the ongoing Phase 2 trials of VTX3232 subjects in Parkinson&#x2019;s disease in Q2 2025, and in the setting of obesity with cardiometabolic risk factors in H2 2025, and the Phase 2 trial of VTX2735 in recurrent pericarditis in H2 2025; management&#x2019;s plans with respect to the commitment of internal resources toward further analysis, or development, including future studies, partnerships or other source of non-dilutive financing for tamuzimod in ulcerative colitis and VTX958 in Crohn&#x2019;s disease; the potential for VTX3232 and VTX2735 in multiple cardiometabolic, systemic or neurological diseases; and the expected timeframe for funding Ventyx&#x2019;s operating plan with current cash, cash equivalents and marketable securities.</font></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The inclusion of forward-looking statements should not be regarded as a representation by Ventyx that any of its plans will be achieved. Actual results may differ from those set forth in this press release due to the risks and uncertainties inherent in Ventyx&#x2019;s business, including, without limitation: potential delays in the commencement, enrollment and completion of clinical trials; Ventyx&#x2019;s dependence on third parties in connection with product manufacturing, research and preclinical and clinical testing; disruptions in the supply chain, including raw materials needed for manufacturing and animals used in research, delays in site activations and enrollment of clinical trials; the results of preclinical studies and clinical trials; early clinical trials not necessarily being predictive of future results; interim results not necessarily being predictive of final results; the potential of one or more outcomes to materially change as a trial continues and more patient data become available and following more comprehensive audit and verification procedures; regulatory developments in the United States and foreign countries; unexpected adverse side effects or inadequate efficacy of Ventyx&#x2019;s product candidates that may limit their development, regulatory approval and/or commercialization, or may result in recalls or product liability claims; Ventyx&#x2019;s ability to obtain and maintain intellectual property protection for its product candidates; the use of capital resources by Ventyx sooner than expected; and other risks described in Ventyx&#x2019;s prior press releases and Ventyx&#x2019;s filings with the Securities and Exchange Commission (SEC), including in Part II, Item 1A (Risk Factors) of Ventyx&#x2019;s Annual Report on Form 10-K for the full year ended December 31, 2024, filed on or about the date hereof, and Ventyx&#x2019;s subsequent filings with the SEC.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">   </font></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof, and Ventyx undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement, which is made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Investor Relations Contact:</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Joyce Allaire<br>Managing Director</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">LifeSci Advisors<br></font><font><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">IR@ventyxbio.com</font></font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">3</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="z-index:-3;min-height:0.5in;position:relative;"></div>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Financial Tables</font></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Ventyx Biosciences, Inc.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Consolidated Statements of Operations and Comprehensive Loss</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(in thousands, except share and per share amounts)</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(unaudited)</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:50.38%;box-sizing:content-box;"></td>
    <td style="width:1.22%;box-sizing:content-box;"></td>
    <td style="width:1%;box-sizing:content-box;"></td>
    <td style="width:9.184000000000001%;box-sizing:content-box;"></td>
    <td style="width:1%;box-sizing:content-box;"></td>
    <td style="width:1.22%;box-sizing:content-box;"></td>
    <td style="width:1%;box-sizing:content-box;"></td>
    <td style="width:9.184000000000001%;box-sizing:content-box;"></td>
    <td style="width:1%;box-sizing:content-box;"></td>
    <td style="width:1.22%;box-sizing:content-box;"></td>
    <td style="width:1%;box-sizing:content-box;"></td>
    <td style="width:9.184000000000001%;box-sizing:content-box;"></td>
    <td style="width:1%;box-sizing:content-box;"></td>
    <td style="width:1.22%;box-sizing:content-box;"></td>
    <td style="width:1%;box-sizing:content-box;"></td>
    <td style="width:9.184000000000001%;box-sizing:content-box;"></td>
    <td style="width:1%;box-sizing:content-box;"></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Three months ended December 31,</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year ended December 31,</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating expenses:</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Research and development</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">$</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">24,821</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">$</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">42,020</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">$</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">117,002</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">$</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">175,767</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">General and administrative</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,597</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,326</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">31,448</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">32,227</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total operating expenses</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">32,418</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">50,346</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">148,450</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">207,994</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Loss from operations</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(32,418</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">)</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(50,346</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">)</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(148,450</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">)</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(207,994</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">)</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other (income) expense:</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Interest income</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(3,056</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">)</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(3,621</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">)</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(13,416</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">)</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(15,074</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">)</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other (income) expense</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(11</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">)</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">28</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">88</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">42</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total other (income) expense</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(3,067</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">)</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(3,593</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">)</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(13,328</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">)</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(15,032</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">)</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">$</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(29,351</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">)</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">$</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(46,753</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">)</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">$</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(135,122</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">)</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">$</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(192,962</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">)</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Unrealized gain (loss) on marketable securities</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(480</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">)</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">577</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">261</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,121</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Foreign currency translation</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(236</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">)</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(120</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">)</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(54</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">)</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(48</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">)</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Comprehensive loss</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">$</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(30,067</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">)</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">$</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(46,296</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">)</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">$</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(134,915</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">)</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">$</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(191,889</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">)</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss per share attributable to common shareholders, basic and diluted</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">$</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(0.41</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">)</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">$</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(0.79</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">)</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">$</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(1.97</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">)</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">$</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(3.30</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">)</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Shares used to compute basic and diluted net loss per share<br>&#160;&#160;&#160;attributable to common shareholders</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">70,810,758</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">59,076,498</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">68,478,172</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">58,542,974</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Ventyx Biosciences, Inc.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Selected Condensed Consolidated Balance Sheet Data</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(in thousands)</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(unaudited)</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:66.993%;box-sizing:content-box;"></td>
    <td style="width:1.62%;box-sizing:content-box;"></td>
    <td style="width:1%;box-sizing:content-box;"></td>
    <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
    <td style="width:1%;box-sizing:content-box;"></td>
    <td style="width:1.62%;box-sizing:content-box;"></td>
    <td style="width:1%;box-sizing:content-box;"></td>
    <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
    <td style="width:1%;box-sizing:content-box;"></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash, cash equivalents and marketable securities</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">$</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">252,943</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">$</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">252,220</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Working capital</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">216,849</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">242,080</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total assets</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">276,563</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">277,693</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total liabilities</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">22,518</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">33,770</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accumulated deficit</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(554,309</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">)</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(419,187</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-kerning:none;min-width:fit-content;">)</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total stockholders' equity</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">254,045</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">243,923</font></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">4</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>img90346216_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img90346216_0.jpg
M_]C_X  02D9)1@ ! @$ W #<  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" "" :(# 2(  A$! Q$!_\0
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M#D8_<S]D+PG+X3^ W@];F,QW?B%+KQ5<!D\MFCUB13ISNN =SZ/!IS9;YL$
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M)U_'ZT^+'@^R'B?P;X@M(?#7Q6^'=Q=O9VGC/PB;M+G%K<@21Z?XDT2<-?\
MAS5G@G6TN3<6EQ%+IVHZA;S?Z 9_@(^.'@WEV(RBK1J9Y0IX/'TJ,IP@HY_E
MM">%S++JLY.*H/$PKXJ.&E5<(-5L'B*CC0ESKX^C/^RLRG&HG[)\T&TKMT9M
M2A-+KRM1<DKO225WH?ZCE%?EI^S]_P %G/\ @G1^T'X9T[6]._:-\%?#+6[J
M%#J'@?XSZI9?#;Q-I%V5'FVDDFO7,.@:MY;$A;OP_K>JVDBX;S58E!ZQXK_X
M*C?\$[/!=O+<:[^V9^S[MA1W:#1/B)HGBJ_98_O^5IOA:?6=0G8=-D%K(Y)
M"DD _P 1U^#>+L-BYX&OPQG\,93FX2P_]D8^53F3M[L84)>TB]XS@Y0FK2C)
MIIGU*Q.&E%35>CRM7YO:02^=WI;JG9KJ?>=%?SH_'G_@Y6_8C\ :A8Z!\%M'
M\=_'34[C6].T^^\01Z5<> O FE:5-?6T6IZO_:7B2V'B;4Y+*P>YNK6QM?"D
M4-[/#'!)J5FDCS1_T26-[;:E96>HV4JSV=_:V][:3K]V:VNH4G@E7/.V2*1'
M'L12SWA#B;AG#9=BN(,EQV44LV^L_4%CZ7L*];ZHL.Z_-AIM8BAR+%46EB*5
M)S4VX*2C)HHXFA7<XT:L*CI\O/R.Z7-?E][X7?E?PMVMKT/X_P#_ (.NO]1^
MQ/\ ]=/CM_Z#\*:\*_X-6?\ DY']I[_LB&A?^IYI5>U_\'6]]8RR?L7V$5[9
MRW]I_P +PEN[&.Z@>]M8KE?A8;::YM%D-Q!%<^7+]GEEC2.<Q2B)G,;[?"?^
M#6#4+"T_:8_:2M;J^L[:YU#X*:)#86UQ=00W%]+'XYTN62.S@DD66Y>.-3)(
ML"NR(-S #FOZORV,O^)5,2N5W^H9@[6=[?ZY597MVY?>OM;78^?J?\E O\=/
M_P!1HG]Q5%%%?Q8?3G\7'_!UO_R4C]C'_L2/C-_Z?OA]6/\ \&I__)9_VN/^
MR8?#K_U*]:J__P '6=[9S_%#]CJTAO+2:[LO!'Q@-[:17,,EU9BYUSP ]LUW
M;([36RW*I(UNTR(LXCE,1?RWVXW_  :K7]C;?&_]JZTN;VSM[N_^&7P^2QM9
M[J"&YO6A\4:U),MI;R2+-<F%"KS>0C^4K*9-H9<_VO2C)_13DE%W_LRH[6=[
M?ZZN5[=N7WK[6UV/F'_R4'_;\?\ U&1_;37^;A_P7W_Y2I_M)_\ 7#X3_P#J
MG? 5?Z1]?YS7_!PWX2U/PS_P5%^,6I7\3I:>-O"'PF\5Z+*Z%5N=.7X>Z#X8
MFDC)X=(M8\-ZK:%@2/,MG!P00/SCZ+TX1\0<RC*24JG"F81@F[.<EF>33:CW
M:A&4K;\L6]DSMSU-X.#[5X7^<*A_2W_P;2$'_@F]. 02/V@?B:" 02#_ &)X
M%.".QP0<'L0>A%?T%5_)#_P;;?MO?L^^ ?V;_BG^SM\6/BKX&^&/C/P]\4=2
M^(OAZ#QWXCTOPI9^)?"OB?P]X?T^\GTC4=;N;*QO+[1=5\/3KJEC'.;J&TU#
M3;I8Y87G:W_8_P".G_!:7_@FY\!+*[?6_P!I/PGX_P!9MB43PO\ !T3?$W6+
MB8=8!>>'!-X9L9%. XU?Q!IRJ6&Y@,D?*>)_"/%&8>*'%U#+^'\XQ]3%YS6Q
M>'6#R[%XF-7#XQ0K4*T9TJ4X.E*%1<U3FY(24HRDG"26V Q.'A@,,YUJ4.6E
M&$N:I&+4H^ZTTVG>ZV^:NM3]3Z*^7OV-_P!K#X??ML_L_>#_ -HKX8V&MZ1X
M3\97GB:QM=(\2K81Z_IESX7\2:IX<N[?58M,O=0LH;B:33!?1Q0WDX6UN[?<
MY8FOJ&OR3'8'%Y9C<7EV/H3PN-P.)K83%X:JDJE#$X>I*E6I3LVN:G4A*+LV
MFU=-JS/2A.,XQG!J4)Q4HR6SC)737JF?AY_P<"?LK']HW]@'QAXNT337O?'?
M[.>J6_Q@T%K>(R7<WAFQA?3/B)IX*(\AM%\+7<_B2>-1^\G\,6><!21_"9^Q
M#^T=J_[)7[5WP._:!TJ281?#WQYI-]XBM(FE!U3P;J#MHWC32&6(AG.I^%M0
MU:SB!#A)Y8I0I>-2/]6+6]&TOQ'HNK^'M;LX-1T;7M+O]&U?3[E%DMK_ $O5
M+26QO[.XC8%9(+JTGE@E1@5>-V4@@FO\J7]N?]FO5OV1/VLOCC^S[J:3&V\
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MC%U</-J-10<N>*;TG&,EK%'95I1K4YTI.2C-6;A)QE:Z>C6U[6?E='\$-_\
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MIL\VL7BZO"U]/;66O"YBFBN)IK:U67]]_$WAGX:?''P'J/AOQ%9>&?B-\/\
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M0PV%PN&X_P"'*.'PV'H4HQIT:%"C"%*C2IQC"G3C&$(J,4E^U]?B#X,D2/\
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M0]G456IAY8>\T[N#I2G-N*LKN]I)M6TU_I'AK%<4\2\-8M<:\,4^"<VQCQV
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MI06KLM93G+>=2I)RG4G+WISE*3=VPHHHK@.T**** "BBB@ HHHH _G>_:O\
MCC:?LS?\%4[#XTZYX+\5^,=!T;X0Z;I4VG^%K:)[V6?6_#&K:5"\<UVT5ILA
MEN0\H:4-L1@N6&VO:YO^"V7P[:*1=/\ V</C7=WQ4BTMIO[$MHIYSQ'%)/#)
M>RPH[$!I([2Y=1RL,API_;-HXV.61&/JRJ3^9% BC!!$: CH0B@CZ$"OHY9Q
MEE>C@X8W)I8FK@\'0P:JQS*M04Z="_*W3A0:BVY3;UDU>W,[)K^:,-X,^*60
M9QQKC."?&W"\,Y3QGQEGG&E;*:_ACE&?5<#F&>?5H5J=/,L?G\*E>-*C@\/3
M@WAZ5*4H.I["//*+_$/_ ()\_"WXX_&#]J3XK_MY_&_P9??#BT\8:+=>'OA]
MX5U*"YL[R:VO1I6G17%O:7\<&H?V3H?A[0X=-CU*[M;5==O=0EOK2/RX9<?M
MU/\ ZF;_ *Y2?^@-4M%>9F683S'%+$2I4Z$*=*CA\/AZ?,Z=##X>"A2I1E)\
MTN5*\I/64G)V2:2_4O##PZP?AGPQ/(*&:X_/\?F&;YOQ'Q#Q#FD:,,?GW$>?
M8J6,S;-*]##1AA\,JU5QIT,-13C0PU&C3E4K5(SK5/Q6_P"")UA?:?\ "+X]
MI?V5W9/+\<+F6-+NWFMW>,^%M$7>J3(C$!E93QPP*G!&*_8CQ;X6T+QQX7\1
M>#/$]A#JGASQ5HFI^'M<TZ< Q7NE:O9S6-];MD';YEO/(JN/FC8JZ$,H(Z!5
M5<[55<G)V@#)]3CO2T9EF$LPS"OF"A]7E6J0J*$9N;IN$(15JG+!MW@I)\L;
M/TN'AEX>X?P\\.<@\/*V.AQ#A<ER_%Y=6QM? 0P=/,:&,QF,Q-6-;+Y8G&PI
MTY0Q<J$Z4L17C4C%N3M-P7\\W@SQ%^T9_P $DO%?BOP7XG\ >(_C=^R'XAU^
MYUOPKXJ\-[WO_"4EWD-)(?*N+/1=3E@C@@UK0]6.GZ5JMY;)J.B:G"9;HS^W
M^*/^"TWPNU;3(])^!GP5^,'Q$^).K1M;Z)X=U;1-/TRP34I$(A2[.@ZOXDU?
M4/+E(+6>FZ>'N54QI>6Q<2I^U$D:2H\<J))'(K))'(H='1@59'1@5964D,K
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M_P!Y&C3A5C##./*^:,)5IRIR<UR1?(HVLU\GE/@=DF0^-N;^,V3YA5P57/\
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M!655/$#%\.UH?5L3DM?C'^T5A:U;%8&4\)B,\JY#/,*JJ3J3C*<I7^"/A_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
G!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>vtyx-20250227.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2025-02-27T14:20:41.7140+00:00 -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema targetNamespace="http://ventyxbio.com/20250227" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:vtyx="http://ventyxbio.com/20250227" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink">
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" namespace="http://xbrl.sec.gov/dei/2024"/>
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" namespace="http://fasb.org/us-gaap/2024"/>
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType roleURI="http://ventyxbio.com/20250227/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document And Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbase id="lnk">
        <link:roleRef roleURI="http://ventyxbio.com/20250227/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="vtyx-20250227.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple"/>
        <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:title="labelLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications"/>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation, State or Country Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Issuer Tender Offer</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Tender Offer</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Title of 12(b) Security</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SolicitingMaterial_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_WrittenCommunications_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl"/>
        </link:labelLink>
        <link:presentationLink xlink:role="http://ventyxbio.com/20250227/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="10010.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="10130.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="10020.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="10000.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="10090.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="10091.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="10100.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="10120.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="10110.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="10040.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="10050.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="10060.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="10070.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="10030.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="10080.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="10140.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="10190.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="10180.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="10210.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="10340.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="10170.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="10220.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="10160.0" priority="2" use="optional"/>
        </link:presentationLink>
      </link:linkbase>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>6
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45582648576256">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document And Entity Information<br></strong></div></th>
<th class="th"><div>Feb. 27, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Feb. 27,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">VENTYX BIOSCIENCES, INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001851194<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-40928<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">83-2996852<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">12790 El Camino Real<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San Diego<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92130<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">760<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">593-4832<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.0001 par value per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">VTYX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>7
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M$4<P!L !0])T> \^>Q\ETWLJ.?]74_P$4$L#!!0    ( &V!6UJ7BKL<P
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M[L#TA(XA+@W#<Z1#BV'7T8B+[,)&G\-8AQ#G\3\Q4EUC!4NJ#AX"#SE&<)W
MD!ILDU;!>"CTN*+N@U6/@24DM0H#E>QV3N7TR@ZN6>1>9!CG*(.XLH/P4:V%
M&@/8-SF0!)?DJG547>EYIM<WDUM)Z.#<@V#OX96,'<V/'W?W U!+ P04
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MUDX:?^:+X3]>?P%02P$"% ,4    " !M@5M:!T%-8H$   "Q    $
M        @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( &V!6UJ5
M711T[@   "L"   1              "  :\   !D;V-0<F]P<R]C;W)E+GAM
M;%!+ 0(4 Q0    ( &V!6UJ97)PC$ 8  )PG   3              "  <P!
M  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ ;8%;6MH\,=IQ!
M/A$  !@              ("!#0@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM
M;%!+ 0(4 Q0    ( &V!6UJ?H!OPL0(  .(,   -              "  ;0,
M  !X;"]S='EL97,N>&UL4$L! A0#%     @ ;8%;6I>*NQS     $P(   L
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64$L%!@     )  D /@(  !44      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="vtyx-20250227.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ventyxbio.com/20250227/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="vtyx-20250227.htm">vtyx-20250227.htm</File>
    <File>vtyx-20250227.xsd</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>13
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "vtyx-20250227.htm": {
   "nsprefix": "vtyx",
   "nsuri": "http://ventyxbio.com/20250227",
   "dts": {
    "inline": {
     "local": [
      "vtyx-20250227.htm"
     ]
    },
    "schema": {
     "local": [
      "vtyx-20250227.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 24,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 23
   },
   "report": {
    "R1": {
     "role": "http://ventyxbio.com/20250227/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document And Entity Information",
     "shortName": "Document And Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "C_9de76f1a-2577-4f63-89af-d1ee4f103041",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtyx-20250227.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_9de76f1a-2577-4f63-89af-d1ee4f103041",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vtyx-20250227.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://ventyxbio.com/20250227/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://ventyxbio.com/20250227/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://ventyxbio.com/20250227/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://ventyxbio.com/20250227/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://ventyxbio.com/20250227/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://ventyxbio.com/20250227/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://ventyxbio.com/20250227/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://ventyxbio.com/20250227/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://ventyxbio.com/20250227/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://ventyxbio.com/20250227/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://ventyxbio.com/20250227/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://ventyxbio.com/20250227/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://ventyxbio.com/20250227/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://ventyxbio.com/20250227/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://ventyxbio.com/20250227/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://ventyxbio.com/20250227/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://ventyxbio.com/20250227/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://ventyxbio.com/20250227/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://ventyxbio.com/20250227/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://ventyxbio.com/20250227/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://ventyxbio.com/20250227/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://ventyxbio.com/20250227/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://ventyxbio.com/20250227/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>14
<FILENAME>0000950170-25-029047-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000950170-25-029047-xbrl.zip
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M,[3Y(S4TYNDN,S$3+,#$<@WL4<?&&O5M:A*/$>),C_08V!Z7K.]C1"\?-\*
M1IFX,[CZ+$A3$8@4.+7(WA])>FUDBCR@(Z3HMR&I[-U>!LL725I1[WJI'(<D
M!%RA?&V4<< *U?QTF^HQ2X:I>E+\J%%.1D%FV<F4585:P.HIY/(Y"$6*U+#%
M7$IKMG^=7:[;E=]7KV9;'P# $EX] ;=(<RE4WM_(E*K>S;?),/F"HM67ZKGJ
MI#X#F@J.$\#5IVBB#J1SFX3^ _P,L+F!S<-^&..>D$*IH=6L,#X<)%DH>0*T
M%U$I<26-31H95$WX20K-XSP9-(R:80URQ).A'PGT1E,_AP&,#6?A?T1#UP9Y
M2=RJ?/DMH/TP&C<NPK[(E( _3_HTK@KZ29XG?2@K)XAI%%[&C4@$DA\<90,:
M5^.X[H6YP/"&B<8@%?@ZI8/;?7^O._7MFTACR8442Y$0N0YYWFL$88Y+;@;=
M_OQ&M[7#H[KL'2 RF(7'XNE:-<>Z9Q#?F3.#SD5Z>]8LB9*T48%Z,0RNBY7U
MDXA/ \5=&U!^Z[0O6B>H>W%\T>H>^6G]?;?5_.V\?=%N==%QYP2UOC;_==SY
MU$+-TR]?VMUN^[2CBE5P7..LC+7-ZM_'W7^U.Y\N3CL'Z*36K(&*9Q%OT=*7
MJR>QLT&T_UX;YI<D5CTK-$*@R89\0F1E%:6+JKY?/+7<.X272RL?3\^_H'EX
M_X#>]N;K"\1G#)08%]M$@&8CW #[ 268>F"],)_H7#<>I19,Z1B5=:6TO"T%
ML=)42Y2[K<FL2KSZ Q'S59*OMV74NSZ9 %+MO-6Y0.>ML]/SBZ>&C VE7PYL
MSH9I-@1C#>4)Z@JF/"JZB9(4Z=8^?XN2 .4](3\-4U NH9?6B/5H?"FD5T=^
MUCV3W()I3J4Z.:MNRMG)T0#BR*\8[,!DF"N3\; 8F*YI-2"DLCQ ***#3#0R
M,: I:-*%.0F-IU7+5V$6^F$$FGRC*ET6@E)\0GE5X[+ID02@'$8) 5BTT:$R
M<J$.F-:WNRCU:X41<U?I&D:+_530;PWU&\L7<YC![5&5UG.A6]0T'=3W*Y'F
M(:-161&^'%:E*J(+E1A9 F4?IJ[,,#,8C>&YMC[U ]T^'48OA:;*R0?(=BZD
M<P'M5\^"@C$ELAP)Z:!!J?HL^-O&C+1>X%.P3,_5?8X%$QP3QPA BMH!MCS/
MM@(2.*ZCKTORGBGKKU78A'NH<-^\VPM'>8/#&]R'7GJR&N9TC,<P+2SBC4+X
MH_#3(4W'R' .E%_T?FD,!,-G* ?^2MI^K)A^J*WU*L7T:S/!UZV5W'1ED,=I
M[#HEED-<'?LZ!XV=N 3[EF5BPEW!K4 8&N>K\HW"?WDN+L-,^GOS#GQ9JPIQ
M[^277]K?0;?ZXROZT#[M-MNM3K/5/4#M3K/V0'5^,0Z8VZ69.K7[D')YV.VW
M1A34*+GPA7BK%AS1#'4'@DF_)4=AC-IYAIH]"M(M?;NZ1?1097_':E\XJ]U"
ME=RX5R.?H\8_O,JCNG$?7H?<.[;-&!@ =[GR[_;,O:TT-A9RYP72EFE$T !D
MK*?[(&,=AGU'$&P+KE/JBD"S_?5(VW;,DA3L!Q57[>: W\UD&.?IN)GP69U=
MQGIE+"@7@S2YDNUL6%D_$1&]IJEX@(Z^M<;G _%!8RYG@IB8:<S"Q.(Z]@R3
M8<XM1Q.!13S;60\^? PC 7W[(MWHVFJ:CHGF&>YK7%S+L[@0#&N"&Z!:^QKV
M#8]*NUSXW#8\7W/7L[@7=-0NX\),$?PSK+1K8L/S;-<R'F%KSQ$BS@N2(842
MO7Z\VLS*[2OQ(+VDIWE/I.A_AVF8\5"Y3U6,%'3Y&7'R=L-4^\+!VTSZ_3"3
M*89(<F%4$.<.B \"8ON\BUK]092,1:J0<I;AH4Y2FPO1>1SFQ_5]W[M*B]?E
M<=;8"Q;:.Y#L0+(#R3:"9.=:>(2UP8G/W8 86'AN@(G.!/9 '\>VJ3N&%1A@
M.ZS)D7_,>2JRK/SS.8R%OE%=0#<<3T.M"#4!D'&"S@6-EK YGGN!B.=X!@$+
MW^$:P<2@''N^+@#8CN:0P 3HLZ=:(&.C"]0=0GO(T+2'&OT3DC1>&$F^));X
M1"QP3L3@V2DN,(GM<0.;Q#&QS(' GFER[)B4V(%+@1Y7SHF8H;@F_'N:7B37
MFW6@=J&CDU!<)O?0V^9&=+!$Q@JUN"T\R\>:9PF -+6PJ_DZIC[A)B>:YZQ9
M8"DWQVEZEB97H=I"M4U.\":@-8PG#ND/YBE]6/APH\IT,=R7PLQT-[!\1\.N
M;1J8:+Z!J>=S;)K"\LS H533UDHN9PG00_1_X4!%C#9)"\"6S8?H#CLO\C9X
MZ$JTD9D?9RDPV'! (]0:"3:4N[?0:1"$3&2;=GN^5(5OYPE>A&? D9!D2=]U
M]\Y-WGQVZ?9:DV.V.U]=-ZQ=POIW\>PFD^_G-ZZA.X<9NA"1&/2@4AG.4D=+
M1$,)+W0,:Z%(M+&*Y;'4R):P,X1&J:43%X."!$H0-1SL&Q;#GLRX(9;IVS9=
M57&2AI^<]<95)<>^3U%Z3M!39C+?<6WL^#8',!H!]DU0837JN*9.'<NP5S;Q
M/B= M&<2$Y\AZ0$T;TQ<\S$I#SL)]0-(J!]8*FV7KW,7LM_!^:7#>5,<?^NW
MB7Q,4I"/J*/VB:2H?"S]!P<H#.3>D/A2<-25CEKTF69YN5ER';M%:N9N;]XR
M&\4?"J=;>\7GS7I9)%PW#)H]P;ZIO=]T,$B301K*C$<0[L@747(M44Y^E)B(
M7/PK"D!M $,FS% HF^" BGF"LK _C'(:BV2816.4T3S,@K&J659(?)AZD9!6
M[C5/;S9!#:&=%-%X7'T+0"M)KF4]&70(989@AO8S(= G$8N41F!30=UAL9']
MN&;4BN&^7<FN6C=LT2W4FCK?26&#/.(ISAO8((J'5.Q>46KY[M9>K@=JLS.D
MIXO^X9T7"W=-W@N&!;LF>4 =X00^=@3W,+$< [L6&):Z$6@^$X3[MK>J8?/O
M-,P!Q#)[=!B7:8[9W:"5GR213P&1<D#G52;Z\QO/(>3P/E-F>Q"O!!" >1I"
M:#!U",3Y$ P-8E@E[=TZ_$&>^;"O.ZCY\1P9IE:#@C?R9<YQ98] 9_M%H#.Q
M TUCU,3,)&"GNX1ASQ4V9HP$OFL8'G.M5=&Y"^*2 =SCRR_ >X$!1SM<G@KA
M3Z"#^B5X[B*R3BAPF"E<GCF]9(+)!(Q'5?)U(K/N:#JW+8)-P7Q,6*!CUW48
MM@W==(7K Z:OS)O/4B'YLCPM4AU%)56$]#0(1+I#ZJGC>*!U-@6F>SFU#MS'
MV/??+H?B1=G7B>2$6S:S7!>;TI]-#.)@CU@!]C@-'%U&$(*5LP%N(7D[RX8B
MW:'ZFE#=%)C(4[N70?6R[%U47_MY7]X&SOM:H]2\T>4*.TND8*D-YIT"IMA*
M:7<!?!O;[Y(V'[%M_Q$G"NC61KHA]W;S-"FNJ[HB;[M^C(GKYWF3Q#83WU([
M[2[DB>O%^62LAUA$L^S),E86@QN]"=2/9K[BC,4=DLX![D5*)4"*4Y_'?:B]
M_X1I9CL,W6'HH]AHISP62W%14>EZH)M ;_#F1H'9W/Z/'W#/AV/ZEF93@G5N
M>6#DR%LV;-_ @:\[8.?H!O-6/H&Z5#O'NN$KV?A(7%HN<@%V!.!(-T_8MP/T
M7[ \FJ8CT"_1%8V& @WD+1*]'^_TG)?'XK:0&#S?=32A<\P-FP!B!QQ[W+2P
M;GNF;0I-T-4W0)72MQ"\3TD)OU_\\76'Y#LDOQ.+H\37J!-@1U@:)H)JV*4>
MQ8S[5F :A%)NKHOC5RX:=8+I'?>7%.HK;1U;3MWM"=2A&:=_HT]1XLO[W40D
M6(Z^T/2;R)\^%?'> ]L?B/'/Y;-KQUSZYP3RQXBI! $8^#=0QX0Z!NE6]#[,
M$ Q9 #0O993F,DVN\YYT\PUD1)]FB(L@C(OC38NPHV;-.7#^YIQY$^U+8G4.
M94ZUZ1VJ"&15!WH#3!O(\U%EBDSA,C1\;"QYAOWMMJ47\:;Z5.NU;?*BWDXE
M>-J+'K8)%UL+\.J>:UKD !9$"!CS=,US7<PM*K?7<@N[ENMA9C";$\(<-Q#K
MV2]8C?V3&GJS&/GS!P=>&PJU@^\PJ -@2W.Y77@G3:D'O$P)%.!E<:*\Z,-,
MJ%(P\3(92E[;J*YG0\55<'*U55_16'9^'4+7$G]CF A\2<55F$&]8'(G*65,
MGD<J"\L;+3E->5:D0?%%+GQSGTY<^-,\K[8,E3P,I9[H5.59+\C\^^JV.V]0
MQE:5!UCJD)<"SX9*8*SS;_<+(C'"/$R+I92QCV$_/JQNT)1?[UX ^-<PR\-@
M7(U(E<* ?M^Y&? F,-:;>$G*-2CN',7JSL,BA#/[ 1HN7A?34NX2&H"$;-#H
MFHZS,DJQYML+OZ-DK7#_V"I<Z<EC=NU<])%1TPQY]_ PRM6&X5/@(F6D%'C!
MU-7%S038EOQ0>SAMK@+"$OFVA;>?QNC.E28'Z'<AK_%%'\(D8Z&ZN;2\X'E?
MLDBI^AG:82F/U9-^^!;TV&P(')8"LY6[M0$_!07V3N,8^#%36:^P)C>,.BU7
M23+X(FEUF )S_WNH3N]7RR5O>$&%8#@13,A=6,C4U2A)#1V#7!A,<EYG>P5%
M-!C"_+,>U 6E6Q2"0^JTO= /<^1Y-5T* :6S-H=I*F/KY;TY\CS-,F'W=6.'
MM C#>'*+<G'!0D5EE<*_&'AJ#6< 3O.<LFI) /I0W1<2-6X62];)>J#.*1W!
M%V#^@.K!T5X01H(K[4]*<>"#0E'X1(J[2UHP!Q(-:+] JVF$GBY<8?6!5#(2
M:;9=@YZ!LJ'_E[2(%>((%(54!=W#8BAYC^8H*\930W. =Q^\9N8=3D[&A7&"
M;C6Y1EBV)%6@,C5\809J:0U.SU=-9U'UZ?D?R$""&*@+-HI1^5)+4T0F,]1%
M+A<"2 H&EA47<+#9$69#!@17]O(8,KKOTL3O[A%8D9 V(ZR\FJ9/B21UC)#,
M\<FF"2=[!.S6ZC=\+N8C[]7;&B!LT\;6Z1U)2K-<6UK13'JAJK?:WE>S9AL;
M20)RK=K]64W;&>J<-=WT._N_JBJ34QSTYPD?K-757"D%G:2VH<P ?4XRQ;:
M=KLC,X]"T!>5>['D93(92\.!NKM@_7N>U\A0=EB]@](.2L]Z_.V/ O:U,E#I
M -@AZJLE9XIZJ0P&7N7C$18CS_M3K_7R_F*,"X+Y&*?:YH*5=P8UE -#NMK+
MM,\'[:W),G1>N P/$%>>EL4W/-,=ZW@FUJ%KY(>DB1WG>%:T:B8P>71&+P5J
M2_N!,G6@[ G-:7&AUKX,.7#I)Y;A ^7 E445L_GZX?PSXN7%];LC0W=1W6>-
MZCX$:<KS=U[0;LSVI\[QQ6_GK>[3>H'O F:;_.%G4ZDK16;-WT,@D2)@L&SH
M:TY*#A]&8\3H4*;1J !56@2FH!L?="H  WR0\:M<!NMZ- IDT$<VI#2OLH ,
MZ UCJ*.: ]+H)2D @-]VW&_A?EC[$9M.R2/J/*+*O4/;3B5TIS[M +(#R+8#
MY&FW)O[>ZES\\15]:)]VF^U6I]GJ'J!VISDWWK,]SO,=7NX L@/(JP7(2U:G
M2,U\GLS>Y<*GH*8WGAD'MQM"BQW/.VC=A=:'\0;O -G^4RM66JP-9$_4LSHZ
MIW\-T9>D1Y=.H'@IK/=E"+<=0'8 ^=%W\F_&MKWA9 ?HK%<[J:ES>)J]4 1W
M+B8L=K*<J&!&DN[B1+LXT=TXT5'=3_CX_4]']5[>C][_/U!+ P04    " !M
M@5M:(_&W\H4(   .80  $0   '9T>7@M,C R-3 R,C<N>'-D[5SM<]HV'/Z^
MOT*C7]I;C8V3+ L7TF-)L^.6)KE ;[WM=CUC"Z*KD9AL!_CO)]F6WY -@=@&
MCGYH'/NG1\^C-TM/)%]^FD]L\ *I@PCN-%I-K0$@-HF%\+C3^-I7NOWK7J_Q
MZ>JGRY\5!=S<]N[!/9R!KNFB%WB#'-,FCD<A>-__\@%\^_WI#O3-9S@QP TQ
MO0G$+E# L^M.VZHZF\V:U@AAA]B>R[)SFB:9J$!10O!K"@U^']P8+@1M7=//
M%$U7]/-!ZY3]UCYM-<];I]HOFM;6M$0R,EU0-'YVP7OS ^"I6-X80]N&"W"+
ML(%-9-B@+W+]"'K8;(*N;8,GGLP!3]"!] 5:S0!T[EAM)Q#A&G0,W7MC IVI
M8<).(Y3RPH0MYD-$? D\3TW7SQO <%V*AIX+;PF=W,"1X=ENI^'A_SS#1B,$
M+5:Z-N3%D@I(/&;5@9TVQ-Y$CW*;#ZG=)'3,,])4.'<A=M#0A@H/@]0O-$?1
M>=T%R9F"*#$O]=E)F%QKJ=^^W 4U)()MA'^DHA/9:2<J?SPT'"C"/4<9&\8T
M2C$RG*$?'3[@)$]%L 516H4#S>:8O*CL02KPA17GRM(-Q3$<RY45CG:F!@^3
MH:A &VN++FL>D;;Y4EF$)=>ZN+A0_:>-JY\ \)L(FDP)=4'04NZ(Z5=#06;\
M-T7DJ/!;2DM73EI-!M8 >*F-%=!5MR,AJG0C$E%[V)2$J"2>^UE>OM):72M'
M)Z^I\0N%7Q3FN=1 7Y>IM#>HT'8=<:>0@KPSQ10,C(GKY\MOB9O3*<(C$MQA
M]W@-M2FQX6 QA8!??'WJK>A<JFO,"2:3A<KC53%XBY]=;'W&+G(7/981G?@,
M&@"Q4>:)A7]?*USP$PPMR-X%R-?2TO@_]J9(O#2B2P8& C20@+M4LR 9>,^!
MU@.^\J^GE(WP."BX.W8C3!R&%"0T#=OT[->GBVGE)@MOBGI*UY[H9'X1V^&H
MDZW>)S@JLW;]X:[]3.&HT^##LR+0>.-]MWZ]AT N$]EI.*P3V>'8D1)L#*'-
MRRJ,YCP+!B%?AC\<"W3D\@013#I7_Y5IL==KG&V4,3%3H3;OUX2FY:\_KKQC
MOWR_)FQ"U1TZ+C5,5R#YU#J-Y>=J-:2ZK((L?^9A&V,)J?3SBDA=L[;29=.^
M:V)!64$E'U=$2;3E1T@18<W9XK-1"3=Y7,4D^<A1P,U_7!&EH.-W+8N-M4[X
M@_5$V)+PRX^MF:S^"K)Z+61YEWB@ S+#JZ@F(NL@^DC89-7^&TUS^G9!<!UT
M^VQV !_H(R4O*%@1%!+.AE=*^9IU;6K8/?9*F_\)%[E<LW&5DOS,5J9CA,=_
M4#)SGZ_)9&K@?*KRZ$H)WR(;WGN3(:2Y+!,AE5+K89-0MOCP)U1^T[LF'JO;
M16'?*DY5J8 G.$9\NH-]+R67<2:L4HH#8]ZS6(=!(Q2L[%:TA;SXBDCS]:?]
M^$QP?IM="JF(VB-E#6W"YA^F[W3U',>#=, GX/1A-))279FD'NJO(ET#W3XT
M/<K:8DL?#O@"2$)R*:1B:I_GYK.!QS"GWTO#JJ)(;&2R13H>?V%C(T6&+2.X
M'%01O0$UN O?7TR&1,8L_;PB4G^QRF)K:=[N/1P.?(Z$G#Q.1I*GX?8KN^)_
M<H!8^=I/K][9?(MX5#HG2ZVDO]O#J)S6\@\X3N/*QP#_")1_0V/&?_K6?%.+
M[ WY1AB @Y3)-KG\WK1PN6W',0 '*9.L=#V^(>O(>PS  $/S_RA5!7^^9M^6
M-L<HDVON^GU#XJ&]&R)]%!> 8X('7(L6O0PM@QFI3$N\_G\C)7Y?)A1PR,I4
MI)R!-Q(28 (&6OJH5&0:O)$:'Y77B\ M7T_&6-A.2 @&?#3 X,KG+W4;ME,A
M($& "4+0\K7$GL1V C@."(#*)UUH36RG(P6=Z!UA!A7U^+23L9VB& MPL/+)
MYU@;VZE@H""-6D%KRUH@&TKP88"/4P'I56;(AB(8K&(F<$$ # )DX$-7**L$
M054IR7HJ&_+WTP(R BW]_? #$*A5,$_:+1NR%U! 8)4^."U;,9M2CX" 0"J3
M=\JHV;2M!!@@ "F3K=2YV9!UB 728&NP[]*T=6504V3/+E<P""-4D["!8>HJ
M 9DP^8B2B6P7ALB.Y!E+>=Y5%52E>S<$U65/J4ZJLAT=4:%F_:0ZB1;N\Q",
M\TVE7:">W/V191S92'427;DG1+ N-I1V48*^K@1]MR0L[Q^1"LB81SM#7[JK
M1*I@V3C:&1$Y>TVD,F2>4?U"<G:@I!7(7*+ZJ1?N2TD+R+>)ZI>QO%LES3UC
M"]5/>*T]+&D-JUVB^F7)=[:D=4C,H/J)K]CODE90Y C5*25O%XQ@+_5_ZB2\
M[MX8(6 M+VB'!*TO99=$Y.VC$=2EAL\N$);MKLF27O)Z:B6>N^<FHBUW>>HD
M+=V)(_@NNSMU4BW<GR,HYUL\R7,Y"9>&K6-^9$_L9,]4R=RA-S^-%![SR>:=
M-K>.IWV.IWV.IWW*I70\[5,)V>-IG^-IG^-IGS(('T_['$_['$_['$_['$_[
M'$_[%&TQ.9[V><O3/LF%^YO8(5.#,CS%?$:V]<HM'IDE,J&L/W<:+4UK:?Q+
M6E.VT.-MM=-@RP3/863(E-.6-XE=$I9>9D>Z6B=[KBMGK1Y7G'X@ H-U?JQ+
MVW-=!69!+/+B0$7J*9&M Q*9-"?B4>:@&FO&UHA5[OM04^R&Q#KW_5V88Z'$
M/?+T( 3FV"^QS+.#D)DT;6)MOQZ$MA6N3RSW_"#D9CVB6-^^3U-7&$RQT-_V
M7.BR*16_-_9]6%WM:L5:]WWF6F2#Q2KWO;4NNV>1-GW?9SER^RW2=[+OO5'F
MW<4M<]]?B!GK+VZ6^[[(R+$/XYI[S<PMW(^4W?J3^9PR_X]_.#FX?:EFOH\=
MWDA\13NX$WS3^^I_4$L#!!0    ( &V!6UJ0O(VB+R$  )9- @ /    =G1Y
M>"UE>#DY7S$N:'1M[5U=>]LVLKX_OP(GVVSMYU"*1'U9<K;/29RDF]TVR=K9
M=GMU'HB$)"04H1*D;?77GQF I*@/N[9B290TN7!LB02!P>"==P:#X<M1/ Y^
M^"_V<B2X#_^SE[&, _'#V_]4NMUJ_>4+^R=<\"*]XF5?^5.FXVD@_O9LPGU?
MAL/>V>3V?,RCH0Q[/(G5?\OQ1$4Q#^/S9Z917UYGM_Q1D:$O;GN5QOE8AI61
MD,-1W*M56S(\GR@M8ZG"7B0"'LMK ;>_? $WFT8F61,#%<85+?\0O7IM$J</
MKL1J8O\V7P_X6 ;3WF<Y%II]$#?L4HUYF%W;5W&LQKW:>2QNXPH/Y!">B1W!
M!^+]V:,\%:BH]Y>:^7=^,Y*QJ.@)]T1O$HG*3<0G]G$W=AA]%?CG"]V[KSOF
MNZ\B"E&(H0J%D<F-].-1;R#CB@??"R/%M[<CV9<QL[."]X%D)MN0BP<=$!$*
M1HZ'3$?>WY[!+]U:H]EVZ^W_JU6_3(;/& _BE9^G7;-#JI^YH"CIE+<Z\/NS
M[8^BE-/["_PWO66OI=*>%*$'S5P*7$.:O5-)%(_8OQ(>P0@8#WWV+@D"]IO@
M$7-K;I.]DR$//<D#N$<G =R#%_T=NAQ@M[$I'#Z[4!$TR6/!/D5J& FMMZM)
M@1BLO< >(7#3<D_&\%#O$5/P64T"&0KF\YBS",!.)2"Z0:3&; Q"E9, Y#;B
M6C 7.I_X$IXL;B?"BX7/XE&DDN$(;L$I:2W(%>'/"[C6L$1B,:X$4L<5$8BQ
M0-V",4Y$E"^55( HK%ZSVG+/GI_[4D\"/NT- G&[-!E?$AW+P30;B;D(9 #:
M<F[$7L%'ZEX?>H[C6YJ@F3S@:8W.\QW,V!WSTZQV6FZ]<]9N=MU&I]EQ6\_/
M;U3D5_HP/5][7X680#^#7#PRQ %6C)3ND<JS'_[ZEUN8)?<\FZ:">4J!JE9[
MOM!L>17WE\__<3N-%I,AFX#5A \UNY$ &9'PDBC"E0_Z)3T>^6!=-5[W=S?7
M4+2N,QM+FDJ:NE%-;;@-UVIJ%$M/3GBNK:HO@/U-C>TRNJK&(N9@<J7'(JF_
ML@'W8A61_I+^[EI_^Z";/();#!&8+B,O4+-@RC[!-3+4*OQ>,QBB0.X E_[K
M+N4]:OIUP?7(@86O07J_)_*:!T:<B 9&U@ %0, TFC2P8O#8/@^ ]0JF!NP[
MM^56NS\SKO&O-\!VQWV8G$;=L01Y1M,4&R30H@(8X.AI(IK ASQF 4Q/#,""
M=[2WRXO3%;2[Y3\_$U>O/K W[]_^^-%A%Z\<]D[T(_ ]ILSM&'&VV,F//WU\
M_99]>/OKU:_O+]^>LDJ%+3LP#GL?>E5V\H%KG__>8[]\_NT_I^S$($+=.[<W
MV+_\<X=EGU^H,1B%:?;%J<,X(+H,@;\$""M#@<MO,N+1&$21Q/@Y\^Q-;*"\
M1,,\JY#YXEH$:@*CA2D.U;6))S!P?P(@ZS#[$]2A@8H65BZ&+^1XG(3"@?L&
M 1^/.5B=J6,T,11)I'PQ%*'1'V@P7=<PVECY? J<"[TVZ,+ NFV_%]RV ;IM
MT]QM&^1N6U1PVT:9VP9M1-9OF\B),2CF^WZBX5>MV23UX:I'K:R9VOP='#8[
MU["<44N=3"7!96-"(WQ(/0*ARAC,\P"Q O0 E[T/TP.PC'\-I A\Q) //UU^
M:L"G)N@". &M7&/SF= 12VX4 [T20789<!-X:&HB<*I28N[83F6^8QS!E!L6
MLZ1-3DI\KKGVDH!'5NEF-$B&/JB[P:TJ^SP2.M<_F ;PZT&#(@$#05<T1K#K
MPP41-!RR_A05?02S-(2&@$G):],0#A9'G@W8:KP&[N5D2Y!I+GUVR;\D[&<U
MXJ$#0WD#/T .TD?]Q$Y>C*08L+>W@,]F77P<#*0GHFJ^KG\5IG/PQ#CBWE?L
M':[:0,2"F1YD\ID95R,I[&"!-^8VU;;;/5\PK1:AS$+BU_@93!_'M00$(T1U
M,FL>GQ>"3K.)>2@\(H4+Y(E5 "YS!1@;91H"=8%+K%;=B-2<X CT",>4+5\3
M*R@.9=4 OH'XX@6KFW^4 UBU,@)5'H/D=*HG/(1Q>? ]B,A@%,HI74+X8!AW
MH-17_/@&&LI&CY>;B E>4Q"BD;=.5]D4'@"3#0^YYC) 0U[-E"L#KS)@"=LK
M)"W&)$VK/LC8LIH><!P1&9.A08TV%+/\E)FE?T]\"SZ@ J]"J]VXY'Z6 0 O
M-+'E..,3"G8C@K-8^SZS&NP3,(8!S),JTV+H98M?PL3ZU\A48*ES-LDZB\ S
M47@UHA!@6%R!IHSS;6G6G U%_$)$T5,-3K*Q93-RQ1!GI>7C?T:S9.@%B3'U
MN7GE!MXFR.J" "F8!F0T?'^A"TYFEA&,\;Z+#U>5"3P%3!)(?.'J16*UM[&%
MG5.V@P@O;'X/:!;'O<P-]Z>"X2X7/*2$3H"GGO"XL"!Q , FP,<&_>=](,CS
MA.7!- 48;GK+C03/2821@O]@G47J5@)R"%CLC=JL,<07SMHP4^(KT!NX!* E
M!A6+QUGCRG?@LB!0-X .P(DY>]F/?NC86V#%B% C*;:75MD_@;J(T)\HB>U;
MZ &;R@<B!H_0 S(\%)GO\.'RBIV$R=@, 7PZ*Q,-OXM3Z"-<I<$^"XM!LUO1
MWP.F&>+.]S72P(L*]-@SJ <#C05<<S+2%Y>?3D$BZ1Y5[C!&8A;<D'>RUNJ?
M!9R*:-6MUMJ 'Z4TS4^MQ:]3_3"F#80&3[M&@X:D-O4J,N7TA),K^"AU'F?F
M+T9S.$ _WVB'PP3\Y5F?SLRW"J%A5--B"&(Z'X#0"39A?!3T).Y8%F5"@47&
M3":23.2&363F1U\L>,IO4H98IN5QAY',AL!7&<9UHP-%<RGU7,A[I>&LMVL
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M_P=02P$"% ,4    " !M@5M:.J"ZG:,3   ^L   $0              @ $
M    =G1Y>"TR,#(U,#(R-RYH=&U02P$"% ,4    " !M@5M:(_&W\H4(   .
M80  $0              @ '2$P  =G1Y>"TR,#(U,#(R-RYX<V102P$"% ,4
M    " !M@5M:D+R-HB\A  "630( #P              @ &&'   =G1Y>"UE
?>#DY7S$N:'1M4$L%!@     #  , NP   .(]      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>vtyx-20250227_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="vtyx-20250227.xsd" xlink:type="simple"/>
    <context id="C_9de76f1a-2577-4f63-89af-d1ee4f103041">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851194</identifier>
        </entity>
        <period>
            <startDate>2025-02-27</startDate>
            <endDate>2025-02-27</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="C_9de76f1a-2577-4f63-89af-d1ee4f103041"
      id="F_79cd09e6-8d88-4f57-8559-2f42b7641899">0001851194</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="C_9de76f1a-2577-4f63-89af-d1ee4f103041"
      id="F_20c918c3-cecf-4582-9a76-0ab6a349c447">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="C_9de76f1a-2577-4f63-89af-d1ee4f103041"
      id="F_4bccf428-64e8-4e8f-bfa4-a9301cb41d12">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="C_9de76f1a-2577-4f63-89af-d1ee4f103041"
      id="F_753981bd-eced-472f-896f-59965f4f7871">2025-02-27</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="C_9de76f1a-2577-4f63-89af-d1ee4f103041"
      id="F_1a457481-b1d8-4484-b553-4d8ed5fe20dd">VENTYX BIOSCIENCES, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="C_9de76f1a-2577-4f63-89af-d1ee4f103041"
      id="F_1c04eaf4-b91b-4d7c-b7e4-6ed1aa8ef06b">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="C_9de76f1a-2577-4f63-89af-d1ee4f103041"
      id="F_0c8dce43-c0c5-45d1-923c-dd570ef54967">001-40928</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="C_9de76f1a-2577-4f63-89af-d1ee4f103041"
      id="F_0595deec-0ed2-44b0-b29a-896ebd629b08">83-2996852</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="C_9de76f1a-2577-4f63-89af-d1ee4f103041"
      id="F_d4bd8f42-e98f-41ce-9996-631725f2103d">12790 El Camino Real</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="C_9de76f1a-2577-4f63-89af-d1ee4f103041"
      id="F_497924d1-7d04-42ad-9b1e-d17074f3f63c">Suite 200</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="C_9de76f1a-2577-4f63-89af-d1ee4f103041"
      id="F_4f3469d2-3473-4f78-933d-73a46f8a7921">San Diego</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="C_9de76f1a-2577-4f63-89af-d1ee4f103041"
      id="F_a5d6e95b-095e-4fa5-80b1-ab4d3d40973d">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="C_9de76f1a-2577-4f63-89af-d1ee4f103041"
      id="F_418f5b70-8632-40b2-a9bd-33e593f7aa00">92130</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="C_9de76f1a-2577-4f63-89af-d1ee4f103041"
      id="F_e0aa5148-a007-4a27-b25c-91aa8453b66a">760</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="C_9de76f1a-2577-4f63-89af-d1ee4f103041"
      id="F_ac3cb786-7b6d-4f2f-b370-0a7831a7526d">593-4832</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="C_9de76f1a-2577-4f63-89af-d1ee4f103041"
      id="F_dfa7e7fb-7ed9-4572-8527-12f0bce4db69">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="C_9de76f1a-2577-4f63-89af-d1ee4f103041"
      id="F_46f00ca3-c34d-484c-98e6-cc4fb8229c85">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="C_9de76f1a-2577-4f63-89af-d1ee4f103041"
      id="F_1701d654-3ecb-4cf1-887c-62138e8b00c9">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="C_9de76f1a-2577-4f63-89af-d1ee4f103041"
      id="F_4d56c588-3a27-4247-945f-9daf712986f0">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="C_9de76f1a-2577-4f63-89af-d1ee4f103041"
      id="F_73b506a4-1d59-4fe6-86b2-fb171ee12c92">Common Stock, $0.0001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="C_9de76f1a-2577-4f63-89af-d1ee4f103041"
      id="F_9b870e1d-d264-4ffd-9d35-169363e0ea21">VTYX</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="C_9de76f1a-2577-4f63-89af-d1ee4f103041"
      id="F_da4b0a7f-7e50-4ea0-8a9a-cdb5f324aad3">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="C_9de76f1a-2577-4f63-89af-d1ee4f103041"
      id="F_cc910988-d5ae-4fd5-8589-c2c6d44c78fe">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
